The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The effects of β-glucan on human immune and cancer cells
Open accessAbstract
Non-prescriptional use of medicinal herbs among cancer patients is common around the world. The alleged anti-cancer effects of most herbal extracts are mainly based on studies derived from in vitro or in vivo animal experiments. The current information suggests that these herbal extracts exert their biological effect either through cytotoxic or immunomodulatory mechanisms. One of the active compounds responsible for the immune effects of herbal products is in the form of complex polysaccharides known as beta-glucans. beta-glucans are ubiquitously found in both bacterial or fungal cell walls and have been implicated in the initiation of anti-microbial immune response. Based on in vitro studies, beta-glucans act on several immune receptors including Dectin-1, complement receptor (CR3) and TLR-2/6 and trigger a group of immune cells including macrophages, neutrophils, monocytes, natural killer cells and dendritic cells. As a consequence, both innate and adaptive response can be modulated by beta-glucans and they can also enhance opsonic and non-opsonic phagocytosis. In animal studies, after oral administration, the specific backbone 1-->3 linear beta-glycosidic chain of beta-glucans cannot be digested. Most beta-glucans enter the proximal small intestine and some are captured by the macrophages. They are internalized and fragmented within the cells, then transported by the macrophages to the marrow and endothelial reticular system. The small beta-glucans fragments are eventually released by the macrophages and taken up by other immune cells leading to various immune responses. However, beta-glucans of different sizes and branching patterns may have significantly variable immune potency. Careful selection of appropriate beta-glucans is essential if we wish to investigate the effects of beta-glucans clinically. So far, no good quality clinical trial data is available on assessing the effectiveness of purified beta-glucans among cancer patients. Future effort should direct at performing well-designed clinical trials to verify the actual clinical efficacy of beta-glucans or beta-glucans containing compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides
S., W. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1076-7 · Cited by 2,141
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
Progress in Clinical and Biological Research
Smyth, J. F. (1979) · Journal of Clinical Pathology · doi:10.1136/jcp.32.7.742-d · Cited by 1,543
Dectin-1 Mediates the Biological Effects of β-Glucans
Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. J., & Gordon, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021890 · Cited by 1,205
Dectin-1: a signalling non-TLR pattern-recognition receptor
Brown, G. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1745 · Cited by 1,158
Bohn, J. A., & BeMiller, J. N. (1995) · Carbohydrate Polymers · doi:10.1016/0144-8617(95)00076-3 · Cited by 924
Rogers, N. C., Slack, E. C., Edwards, A. D., Nolte, M. A., Schulz, O., Schweighoffer, E., Williams, D. L., Gordon, S., Tybulewicz, V. L., Brown, G. D., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.004 · Cited by 895
Immunomodulation and Anti-Cancer Activity of Polysaccharide-Protein Complexes
C.Ooi, V. E., & Liu, F. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374705 · Cited by 866
Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity
Gross, O., Gewies, A., Finger, K., Schäfer, M., Sparwasser, T., Peschel, C., Förster, I., & Ruland, J. (2006) · Nature · doi:10.1038/nature04926 · Cited by 853
Taylor, P. R., Brown, G. D., Reid, D. M., Willment, J. A., Martinez-Pomares, L., Gordon, S., & Wong, S. Y. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3876 · Cited by 655
Medicinal importance of fungal β-(1→3), (1→6)-glucans
Chen, J., & Seviour, R. (2007) · Mycological Research · doi:10.1016/j.mycres.2007.02.011 · Cited by 519
Hong, F., Yan, J., Baran, J. T., Allendorf, D. J., Hansen, R. D., Ostroff, G. R., Xing, P. X., Cheung, N.-K. V., & Ross, G. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.797 · Cited by 472
Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages
Herre, J. (2004) · Blood · doi:10.1182/blood-2004-03-1140 · Cited by 464
Mushrooms, Tumors, and Immunity: An Update
Borchers, A. T., Keen, C. L., & Gershwin, M. E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900507 · Cited by 381
Goodridge, H. S., Simmons, R. M., & Underhill, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3107 · Cited by 357
The use of mushroom glucans and proteoglycans in cancer treatment.
Kidd, P. M. (2000) · PubMed · Cited by 347
Polysaccharide processing and presentation by the MHCII pathway
Cobb, B. A., Wang, Q., Tzianabos, A. O., & Kasper, D. L. (2004) · Cell · doi:10.1016/j.cell.2004.05.001 · Cited by 340
Rice, P. J., Adams, E. L., Ozment-Skelton, T., Gonzalez, A. J., Goldman, M. P., Lockhart, B. E., Barker, L. A., Breuel, K. F., DePonti, W. K., Kalbfleisch, J. H., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085415 · Cited by 332
Petsko, G. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.538 · Cited by 327
Dectin-1 and its role in the recognition of β-glucans by macrophages
Herre, J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.007 · Cited by 278
Tang, W., Liu, J.-W., Zhao, W.-M., Wei, D.-Z., & Zhong, J.-J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.001 · Cited by 275
Knudsen, K. E. B., Jensen, B. B., & Hansen, I. (1993) · British Journal of Nutrition · doi:10.1079/bjn19930147 · Cited by 232
Zimmerman, J. W., Lindermuth, J., Fish, P. A., Palace, G. P., Stevenson, T. T., & DeMong, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22014 · Cited by 223
Dixon, D. R., & Darveau, R. P. (2005) · Journal of Dental Research · doi:10.1177/154405910508400702 · Cited by 203
Vos, A. P., M'Rabet, L., Stahl, B., Boehm, G., & Garssen, J. (2007) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v27.i2.10 · Cited by 200
Taylor, P. R., Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., & Gordon, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1157 · Cited by 195
Human monocyte scavenger receptors are pattern recognition receptors for (1-->3)-beta-D-glucans.
Rice, P. J., Kelley, J., Kogan, G., Ensley, H. E., Kalbfleisch, J. H., Browder, I. W., & Williams, D. L. (2002) · PubMed · Cited by 183
Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies
Cheung, N.-K. V., Modak, S., Vickers, A., & Knuckles, B. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0321-3 · Cited by 180
Lin, Y.-L., Liang, Y.-C., Lee, S.-S., & Chiang, B.-L. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804481 · Cited by 173
Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans
Rice, P. J., Kelley, J. L., Kogan, G., Ensley, H. E., Kalbfleisch, J. H., Browder, I. W., & Williams, D. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.140 · Cited by 169
Wakshull, E., Brunke-Reese, D., Lindermuth, J., Fisette, L., Nathans, R. S., Crowley, J. J., Tufts, J. C., Zimmerman, J., Mackin, W., & Adams, D. S. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(98)00059-9 · Cited by 163
Effect of Maitake ( Grifola frondosa ) D-Fraction on the Activation of NK Cells in Cancer Patients
Kodama, N., Komuta, K., & Nanba, H. (2003) · Journal of Medicinal Food · doi:10.1089/109662003772519949 · Cited by 137
Iwabuchi, K., & Nagaoka, I. (2002) · Blood · doi:10.1182/blood.v100.4.1454.h81602001454_1454_1464 · Cited by 133
Chen, X., Hu, Z., Yang, X.-X., Huang, M., Gao, Y., Tang, W., Chan, S. Y., Dai, X., Ye, J., Ho, P. C., et al. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.08.026 · Cited by 131
Bioactive Polysaccharides from Traditional Chinese Medicine Herbs as Anticancer Adjuvants
Chang, R. Y. (2002) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555302320825066 · Cited by 128
Demir, G., Klein, H. O., Molinas, N., & Tüzüner, N. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.08.011 · Cited by 125
Orally administered marine (1→3)-β-d-glucan Phycarine stimulates both humoral and cellular immunity
Větvička, V., Dvořák, B., Větvičková, J., Richter, J., Křižan, J., Šíma, P., & Yvin, J. (2006) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2006.08.009 · Cited by 118
Can maitake MD-fraction aid cancer patients?
Kodama, N., Komuta, K., & Nanba, H. (2002) · PubMed · Cited by 112
Sato, T., Iwabuchi, K., Nagaoka, I., Adachi, Y., Ohno, N., Tamura, H., Seyama, K., Fukuchi, Y., Nakayama, H., Yoshizaki, F., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106069 · Cited by 106
The function of human NK cells is enhanced by β‐glucan, a ligand of CR3 (CD11b/CD18)
Renzo, L. D., Yefenof, E., & Klein, E. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210726 · Cited by 94
Gao, Y., Tang, W., Dai, X., Gao, H., Chen, G., Ye, J., Chan, E., Koh, H., Li, X., & Zhou, S. (2005) · Journal of Medicinal Food · doi:10.1089/jmf.2005.8.159 · Cited by 93
Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes
Karumuthil‐Melethil, S., Perez, N., Li, R., & Vasu, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8323 · Cited by 91
Chan, W. K., Cheung, C. C., Law, H., Lau, Y., & Chan, G. (2008) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-1-9 · Cited by 84
Self-citationMcEachrane-Gross, F. P., Liebschutz, J. M., & Berlowitz, D. R. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-34 · Cited by 83
The Pattern Recognition Receptor Dectin-1: From Fungi to Mycobacteria
Schorey, J. S., & Lawrence, C. (2008) · Current Drug Targets · doi:10.2174/138945008783502430 · Cited by 83
Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-d-β-glucan
Modak, S. I., Koehne, G., Vickers, A. J., O’Reilly, R. J., & Cheung, N. V. (2005) · Leukemia Research · doi:10.1016/j.leukres.2004.10.008 · Cited by 74
Lehne, G., Haneberg, B., Gaustad, P., Johansen, P. W., Preus, H. R., & Abrahamsen, T. G. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02962.x · Cited by 74
The Biological Role of Dectin-1 in Immune Response
Sun, L., & Zhao, Y. L. (2007) · International Reviews of Immunology · doi:10.1080/08830180701690793 · Cited by 60
Yang, C., Chien, L., & Tai, C. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2007.7181 · Cited by 53
SOLUBLE GLUCAN PROTECTS AGAINST ENDOTOXIN SHOCK IN THE RAT
Vereschagin, E. I., van Lambalgen, A. A., Dushkin, M. I., Schwartz, Y. S., Polyakov, L. M., Heemskerk, A. E. J., Huisman, E., Thijs, L. G., & van den Bos, G. C. (1998) · Shock · doi:10.1097/00024382-199803000-00006 · Cited by 46
Nakano, T., Oka, K., Hanba, K., & Morita, S. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0053 · Cited by 33
Miyakoshi, H., Aoki, T., & Mizukoshi, M. (1984) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(84)90057-2 · Cited by 30
Dushkin, M. I., Сафина, А. Ф., VERESCHAGIN, E. I., & Schwartz, Y. S. (1996) · Cell Biochemistry and Function · doi:10.1002/cbf.685 · Cited by 24
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Tumor-associated macrophages: from basic research to clinical application
Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Hyde, K. D., Xu, J., Rapior, S., Jeewon, R., Lumyong, S., Niego, A. G. T., Abeywickrama, P. D., Aluthmuhandiram, J. V. S., Brahamanage, R. S., Brooks, S., et al. (2019) · Fungal Diversity · doi:10.1007/s13225-019-00430-9 · Cited by 811
Fish immune system and its nutritional modulation for preventive health care
Kiron, V. (2012) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2011.12.015 · Cited by 599
Feeding the microbiota–gut–brain axis: Diet, microbiome, and neuropsychiatry
Sandhu, K. V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017) · Translational Research · doi:10.1016/j.trsl.2016.10.002 · Cited by 491
Metadata
- Authors
- Chan, G. C.-F., Chan, W. K., & Sze, D. M.-Y.
- Venue
- Journal of Hematology & Oncology
- Published
- 2009-06-10
- Volume
- 2
- Issue
- 1
- Pages
- 25-25
- ISSN
- 1756-8722 (ISSN-L)
- OpenAlex
- W1987051998
- Cited by
- 862
- References
- 54
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.